R-Zero vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
R-Zero combines UV-C disinfection hardware with IoT sensors and AI to reduce pathogen transmission and cut HVAC energy costs 20–40% in healthcare, education, and commercial buildings; raised $58M+.
About
R-Zero is an indoor health and intelligent building platform that integrates UV-C disinfection technology with IoT-connected environmental sensors and AI-driven automation. The company's product suite includes mobile and fixed UV-C disinfection units alongside occupancy and air-quality sensors that feed a building management layer capable of autonomously adjusting HVAC systems to reduce energy consumption by 20–40% without infrastructure changes. Customers include healthcare systems, K–12 schools, universities, and corporate facilities managers seeking to simultaneously reduce infection risk and operating costs.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.